Application 210910
- Type
- NDA
- Sponsor
- REDHILL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AEMCOLO | RIFAMYCIN SODIUM | TABLET, DELAYED RELEASE;ORAL | EQ 194MG BASE | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 57841-1200 | Aemcolo | Rifamycin | RedHill Biopharma Ltd | NDA | Current |
| 57841-1200 | Aemcolo | Rifamycin | RedHill Biopharma Ltd | NDA | Current |
| 57841-1201 | Aemcolo | Rifamycin | RedHill Biopharma Ltd | NDA | Current |
| 57841-1201 | Aemcolo | Rifamycin | RedHill Biopharma Ltd | NDA | Current |
| 71068-001 | Aemcolo | Rifamycin | Aries Pharmaceuticals Inc | NDA | Current |
| 71068-001 | Aemcolo | Rifamycin | Aries Pharmaceuticals Inc | NDA | Current |
| 71068-001 | Aemcolo | Rifamycin | Aries Pharmaceuticals Inc | NDA | Current |